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Abstract
Background: Quality care of type 2 diabetes is complex and requires systematic use of clinical data to monitor
care processes and outcomes. An electronic decision support (EDS) tool for the management of type 2
diabetes in primary care was developed by the Australian Pharmaceutical Alliance. The aim of this qualitative
study was to evaluate the uptake and use of the EDS tool as well as to describe the impact of the EDS tool on
the primary care consultation for diabetes from the perspectives of general practitioners and practice nurses.
Methods: This was a qualitative study of telephone interviews. General Practitioners and Practice Nurses from
four Divisions of General Practice who had used the EDS tool for a minimum of six weeks were invited to
participate. Semi-structured interviews were conducted and the interview transcripts were coded and
thematically analysed using NVivo 8 software. Results: In total 15 General Practitioners and 2 Practice Nurses
completed the interviews. The most commonly used feature of the EDS tool was the summary side bar; its
major function was to provide an overview of clinical information and a prompt or reminder to diabetes care.
It also assisted communication and served an educational role as a visual aide in the consultation. Some
participants thought the tool resulted in longer consultations. There were a range of barriers to use related to
the design and functionality of the tool and to the primary care context. Conclusions: The EDS tool shows
promise as a way of summarising information about patients diabetes state, reminder of required diabetes care
and an aide to patient education. 2012 Wan et al.; licensee BioMed Central Ltd.
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Abstract
Background: Quality care of type 2 diabetes is complex and requires systematic use of clinical data to monitor care
processes and outcomes. An electronic decision support (EDS) tool for the management of type 2 diabetes in
primary care was developed by the Australian Pharmaceutical Alliance. The aim of this qualitative study was to
evaluate the uptake and use of the EDS tool as well as to describe the impact of the EDS tool on the primary care
consultation for diabetes from the perspectives of general practitioners and practice nurses.
Methods: This was a qualitative study of telephone interviews. General Practitioners and Practice Nurses from four
Divisions of General Practice who had used the EDS tool for a minimum of six weeks were invited to participate.
Semi-structured interviews were conducted and the interview transcripts were coded and thematically analysed
using NVivo 8 software.
Results: In total 15 General Practitioners and 2 Practice Nurses completed the interviews. The most commonly used
feature of the EDS tool was the summary side bar; its major function was to provide an overview of clinical
information and a prompt or reminder to diabetes care. It also assisted communication and served an educational
role as a visual aide in the consultation. Some participants thought the tool resulted in longer consultations. There
were a range of barriers to use related to the design and functionality of the tool and to the primary care context.
Conclusions: The EDS tool shows promise as a way of summarising information about patients’ diabetes state,
reminder of required diabetes care and an aide to patient education.
Background
General Practitioners are playing an increasing role in
delivering effective care to prevent the progression of
type 2 diabetes. There is evidence that systematic pri-
mary care can achieve standards of care as good or bet-
ter than hospital outpatient care for type 2 diabetes [1].
However, diabetes is a complex disease to manage and
there are many barriers to patients achieving their
optimum treatment and management goals. For example
the AusDiab study has shown that only one in seven
patients being treated for type 2 diabetes is achieving the
three key targets of glucose control, blood pressure man-
agement and cholesterol levels [2].
The Pharmaceutical Alliance (a collaboration between
Elli Lilly Australia Ltd, Merck Sharpe and Dohme Austra-
lia Ltd and Sanofi Aventis Australia Ltd), in consultation
with an expert reference group commissioned the
development of an electronic decision support (EDS) soft-
ware tool designed to support primary care practitioners
in the care and management of their patients with type 2
diabetes. The tool is based on Diabetes Australia/ RACGP
guidelines [3] for the management of type 2 diabetes and
was designed to link and share data with the General Prac-
titioner's (GP) clinical records systems. The software tool
links with two of the leading desktop software products:
Best PracticeTM and LocumTM. Key features of the tool
are described in Table 1.
The aim of this qualitative study was to evaluate the up-
take, use and perceived value of the EDS tool in the care
of patients with type 2 diabetes and describe the impact of
the EDS tool on the primary care consultation from the
perspectives of general practitioners and practice nurses.
Methods
Design
This was a qualitative study of semi-structured tele-
phone interviews with users of the EDS tool.
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Ethical Approval
Ethics approval was given by the University of New South
Wales Human Research Ethics Committee (approval
number HREC 09064). The research was conducted in
accordance with the Helsinki Declaration.
Recruitment
There were 68 General Practitioners (GPs) and 9 Prac-
tice Nurses (PNs) from nine Divisions in New South
Wales, Western Australia and Victoria who were users
of Best Practice or Locum software and who expressed
interest in being part of a demonstration project to use
and evaluate this tool. These GPs and PNs were invited
to participate in the study by three rounds of letters, and
followed by reminder phone calls and faxes to non
responders. GPs and PNs who had used the EDS tool for
at least six weeks were eligible to participate as it was
considered that this was a reasonable amount of time to
have had an opportunity to use the tool and form a view
about its value. Eligible GPs and PNs who agreed to par-
ticipate provided written informed consent.
Intervention introduction into practices of the EDS tool
The EDS tool was installed in participating practices by
a team from the Pharmaceutical Alliance. The GPs and
PNs in the practices were encouraged to make use of the
tool as they saw fit with no restriction on how often or
with which type 2 diabetes patients it should be utilised.
There was a variable degree of orientation provided to
GPs and PNs, however, continuous technical support
was offered by the Pharmaceutical Alliance team.
Data collection
Data collection was completed independently by the
team from University of New South Wales. GPs pro-
vided background information about themselves and
their practice demographics by completing a question-
naire at the beginning of the study. After at least six
weeks of using the EDS tool, GPs and PNs were inter-
viewed by phone for approximately 20–30 minutes.
Interviews were audiotaped, and professionally tran-
scribed and checked. The interviews explored: use of the
EDS tool; impact of the tool on the consultation process;
impact of the tool on diabetes care; barriers to the use of
the tool and suggestions on its improvement.
Data analysis
The qualitative data from GP, PN and patient interviews
were coded and analyzed using NVivo 8 software [4].
The accuracy of transcripts was checked by QW prior to
being transferred to the QSR NVivo 8 software for ana-
lysis. Out of 17 interviews, four interviews (three GPs,
one PN) were pilot coded by QW, MM, SP and NZ to-
gether to develop an initial coding framework. Where
there were differences these were discussed to resolve
them until consensus about the coding was reached.
Based on the coding framework, QW coded the rest of
the interviews and modified the nodes in the analysis
process to best fit the data. Thematic analysis was used
for qualitative data analysis [5,6].
Results
Recruitment and GP background findings
Out of 68 GPs invited: 22 consented to participate in the
study; 14 refused and 32 did not respond to the invita-
tion. The practices of the 46 GPs who either refused or
did not respond were contacted to try to ascertain why
they were not interested. The reasons given were: the
GP did not use the EDS tool; were too busy; had no
interest, moved to other practices or unknown. Out of
nine PNs invited, all responded with two consenting to
participate in the study and seven nurses declining to
take part. The reasons for not participating were: not
using the EDS tool or unknown reason.
In total, 22 GPs and two 2 PNs (who were involved in
diabetes care and education) consented to participate in
this study. All 22 GPs completed the background infor-
mation questionnaire (Table 2) and 15 of them plus 2
PNs took part in the semi-structured interviews. Semi-
structured interviews were also completed with two
practice nurses.
Table 1 Features of the Diabetes EDS tool
Key features •a diabetes ‘toolbar’ showing the patient’s latest key
measurements, highlighting whether these are at the
recommended level or due for a check-up
•brings critical information together in an easy-to-review
format to cover all aspects of the patient’s condition
•allows gps to proactively monitor the patient’s health
status and progress to clinical treatment goals
•links with existing clinical record systems enabling the




•prompts informed discussion through interactive and
informative summary screens
•easy-to-use analytical screens and graphs to highlight
the patient’s progress
•linked to nhmrc and da / racgp diabetes
management guidelines
•provides a workflow oriented approach to data entry
•chronological and cumulative summary
•task reminders
•access to resources for gps and patients




•further information and example of screen grab
available at www.consultdave.com.au/index.html
(accessed 28 may 2012).
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Interview findings
Thematic analysis resulted in 3 major themes which
were described as below.
Use of the tool and impact on diabetes care
When GPs and PNs were asked about their reasons for
using the EDS tool, many reported that it was useful in
giving them a quick summary of their patients’ type 2
diabetes care; the tool also provided a good reminder of
their patients’ risk factor information and any related
care that was outstanding. This was the most common
reason for their use of the tool.
It gives us a . . . very quick summary and . . . very good
reminder of what needs to be done. GP1009
Highlighted whether it’s been done recently, more to the
point whether it hasn’t been done recently. PN 0201
The design of the EDS tool offers multiple screens
which involve different functions supporting the care of
patients with diabetes. These multiple functions were
tailored by participating GPs and PNs and used to a
greater or lesser degree in managing different individual
patients. Many GPs reported that the most useful func-
tion was the side bar screen which provided an overview
at a glance of all the important factors in diabetes man-
agement and a reminder of the outstanding items in the
patient’s type 2 diabetes care. Overall, those two
functions were viewed as the tool’s key role in diabetes
care and we the most commonly used features.
If you don’t have a prompting tool you may forget
something and so on. Here it’s quite hard to forget
something because it’s flashing in red there so it
almost makes you want to do those things in a way.
-GP0101
Acts as a reminder to check certain things like weight,
blood pressure, smoking and so on regularly and it
also reminds me to do blood sort of on a regular basis.
It’s more like a reminder system for me to be honest
but I know anyway but it just keeps me, reminds me to
do again. -GP1303
The extent of use of some of the more detailed aspects
of the tool in practice is variable, partly because of the
tool’s shortcoming such as the speed of the software
causing some delays in the consultation when users
attempt to access these sections, and partly because of a
lack of users’ understanding of the full set of features
contained within the tool.
The more you use it the more your realise it is useful -
GP1303
Both GPs and PNs reported using the tool as a resource
to assist in the process of education of patients about dia-
betes and the targets for control of glycaemia and macro-
vascular risk factors. The fact that information was
presented in a graphical format and presented on the screen
was considered a visual aide to patient understanding.
More understanding on the basis of the patient. If you
just talk and you don’t illustrate, very little of it gets
retained, whereas illustrations help the patient to link
the information to something else in their brain and
they’re more likely to remember it. –GP1701
One of the PNs not only used the tool as a visual aide
but also used it to provide print out patient educational
material relevant to the discussion.
It’s nice to give a visual thing for the actual patient
themselves. It makes them feel included when you
share that information with them and because it
comes from their file also they think that it makes it
seem a little bit more personal. Print it out into,
onto the particular specified screen that you like. So
say for example they’re not to increase their activity
then you can expand and go into that and then you
can print out information so you can take it step by
step –PN 0201




















4 Using electronic records when
consulting (no paper records )
22
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Most GPs and both PNs felt that the use of the tool
positively affected their management of patient lifestyle
risk factors with the focus determined by individual
need. This is because they were reminded or prompted
by the tool to do so.
I discuss it more often because I’m reminded about it
because of the software. –GP1702
The tool reminded GP to reinforce to their patients
the nature of diabetes lifestyle management which
needed to be addressed.
We’re always reminded about things like their weight
and their exercise and things like that and whether
they smoke or drink or all those other things that go on
that screen so it’s probably just reinforcing it again.
–GP1706
The GPs and PNs saw less value and reported less use
of the tools of functions such decision support on use
medicines, making referrals or providing follow-up
reminders. This was often as the clinicians did not see a
need for decision support in this aspect of care. For ex-
ample in the area of medicines for diabetes one GP
commented:
I think it doesn’t affect someone if your knowledge of
diabetes is substantial but if your diabetes knowledge
is not that good it offers a lot of advice of what might
be the best thing to do with –it does depend on the
doctor’s level of knowledge.
–GP0201
The EDS tool provides diabetes guideline information
for clinicians to access during the consultation. Many
GPs and both PNs reported that they were already famil-
iar with the guidelines for diabetes management, but
that the tool did reinforce application of the guidelines
in daily work.
I think the guidelines are essentially buried into the
tool so it’s what tells me whether or not the targets are
reached so it’s, it’s almost like a, a reminder in the
background about the guidelines so the tool applies to
guidelines and informs me how I’m going with each
particular patient. –GP0201
There was a range of views on the value of the EDS tool
in completing an annual diabetes cycle of care. A diabetes
cycle of care is a defined list of care processes to be con-
ducted each year and the completion of the cycle attracts
an incentive payment to the GP from Medicare Australia.
While only a small number of GPs perceived any value of
the tool in this regard both PNs thought the tool helped
in getting the cycle of care completed.
A prompt for the GPs to remind them the patient is a
diabetic, to send them to me for their annual cycle of
care if it’s due. PN0401
Impact on the consultation process
The perceptions of GPs varied on the impact of the tool
on consultation times. Many GPs felt that they tended to
spend longer with their patients when using the tool
compared their usual consultations, however this was
because they were using the tool to provide better qual-
ity of care for their patients. One of the PNs interviewed
felt that the consultation was lengthened, and the other
reported no change.
Problems with the functionality of the tool software
were perceived by some GPs as costing time. Some GPs
thought the EDS tool software itself slowed down their
IT systems and did not always import information ap-
propriately which resulted in the need of adding infor-
mation manually. Additionally, some felt the tool was
distracting them at times from the purpose of their con-
sultation, in particular when the patient was not attend-
ing for a problem related to their diabetes care.
I mean even to load it up and stuff just takes too
much time and it slows down the consultation quite a
lot you know.
–GP1009
I think it takes a bit longer because it’s you know a lot
of ticking and putting things in – it doesn’t always
automatically do it for some reason. GP1303
The use of the tool as a visual aide to patient educa-
tion has been previously discussed. The majority of
GPs said they shared the information displayed by the
tool to discuss issues such as pathology results, cardio-
vascular risk factors, guideline recommendations and
metabolic targets. It also made it easier to illustrate to
patients what they were talking about. The majority of
the GPs and one of the PNs thought their communica-
tion with patients improved by using the EDS tool.
This was because that the tool provided detailed infor-
mation to them when needed and removed the need to
spend time searching different fields of their desktop
software.
By sharing the screen with the patients, many GP
believed that their patients’ understanding of their dia-
betes care improved.
If you just talk and you don’t illustrate, very little of it
gets retained, whereas illustrations help the patient to
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link the information to something else in their brain
and they’re more likely to remember it. –GP1701
Related to improved communication more than half of
the GPs thought use of the tool was of benefit to the
doctor-patient relationship.
I think doing it correctly would reinforce the doctor/
patient relationship and also create more rapport.
–GP1401
One of the PNs thought the tool also helped her com-
municate with the GPs in the practice about the care
provided.
Because when you’re printing out it will document
that down so you can – instead of writing everything
down you, you can communicate more effectively to
the GP. –PN0201
However a few GPs thought the tool interfered with
communication with the patient.
It [the tool] sort of diverts my attention. . .. . . It makes
me focus more on the computer. -GP1705
Some GPs expressed a perception of increased patient
satisfaction and engagement with their diabetes care in
the consultation as a result of seeing their doctor’s inter-
est in using the EDS software.
If I’m focussing on the screen often it will make the
patient focus on thescreen as well and then I’d, I
would point a few things out and then show, show a
few things on the screen. –GP0101
The patient gets happy about it because the thing is
they know the doctor is taking a particular interest in
them, so I think that’s useful, yes. -GP 1007
Most importantly, no GPs or PNs reported that their
patients had any negative experience associated with the
use of the tool during consultations.
Problems/barriers to use and suggestions for
improvement
There were a range of problems identified with the tool
and barriers to use. These included problems with the
functionality of the tool itself and barriers related to the
skills of the users. These problems and barriers are sum-
marised in Table 3.
There was a range of suggestions for improvements.
These included addressing problems with functionality
such as the software running slowly, improving the print-
ing function and also improving integration of the tool
with the practice clinical software program. There were
also suggestions for new functionality such as providing
automatically updated diabetes guidelines via a pop-up or
link and being able to modify the goals of treatment for
individual patients.
A common suggestion for improvement was a request
for a summary information report for the diabetes an-
nual cycle of care. Some GPs were keen to see if the tool
could technically be configured to better assist them in
determining when they had completed a diabetes annual
cycle of care and somehow trigger them to automatically
bill this item.
You would want to know when the last cycle was
completed and whether you have been able to satisfy
all the criteria for a cycle of care for example, and if
the tool could produce a summary of the cycle of care
for example. –GP0101
There was variability into the extent of training and
support that the GPs and PNs had received. Nearly all
participants thought that introductory training was ne-
cessary and there were a range of suggestions on this
and ongoing support
I think it does require a fairly good introduction,
introductory session to show where the effectiveness of
Table 3 Barriers to use of the tool
Barriers related to the tool Barriers related to users
•Loading or opening speed too slow •Users’ poor knowledge with the
tool’s functions
•Sometimes pathology results not
fully uploaded or no results in
the toole.g. eGFR, cholesterol or
urine albumin
e.g. Not aware of other functions
except for the side bar
•Some information not included in
the tool
•Time pressure
e.g. information on vaccinations,
cardiovascular risk
•No financial incentive to GPs to
use the tool
•Problems with the tool’s screene.g.
Screen interferes with the existing
window, too big and cannot
be minimised
•Not fitting the use of the tool
with the consultation process
•Lengthened the consultation time
•Cannot add in new progress notes
e.g. Foot check notes, eye check
notes, action and
improvement notes
•Wrong alert of resultse.g. sometimes
alerts everything in red (as
abnormal), still no change even
when changing the values manually
•No summary information report for
diabetes cycle of care
Wan et al. BMC Medical Informatics and Decision Making 2012, 12:61 Page 5 of 7
http://www.biomedcentral.com/1472-6947/12/61
the tool can, can come in, where you can benefit from
this and how to fit it into a consultation.
–GP0101
Suggestion on the content for the introductory train-
ing included demonstrating the range of capabilities of
the tool, practising on dummy patients and testing on
the practice’s own software system.
In contrast to the introductory training, only some
participants supported the need for providing continu-
ous support as they felt that the tool was pretty straight
forward.
I think because I mean it works actually quite well on
its own. I don’t think there’s much training necessary
really. Maybe you know initial training and that’s it. I
don’t think ongoing support is necessary really.
–GP1303
Among those who thought ongoing support was
needed, suggestions for providing this included having
regular follow-ups by practice visits or telephone calls
and/or a telephone helpline.
Discussion
Health providers are keen to have a tool that helps sup-
port the care of their diabetic patients in their generally
limited consultation times. There is evidence that inte-
grated electronic decision support tools can be effective
in changing routine behaviours amongst clinicians, as
well as improving quality of care provided, but the ex-
tent of impact on patient clinical outcomes over time
remains unclear [7-10]. The EDS tool has a number of
features that have been found in a systematic review to
be critical to success of clinical decision support systems.
These are automatic provision of decision support as
part of clinician workflow; provision of recommenda-
tions rather than just assessments; provision of decision
support at the time and location of decision making; and
computer–based [11].
In this study, the most common reason for using the
tool was its role in providing a summary of the current
state of the patients’ diabetes and reminder of required
diabetes care. These features were also the most useful
functions of the tool experienced by users. GPs and PNs
used the tool in a range of ways to involve patients and
provide better quality care for type 2 diabetes: sharing
screens with patients, increased discussion and better
communication with their patients. To some extent the
tool also reinforced GPs and PNs use of current diabetes
guidelines. Even though the use of the tool was likely to
lengthen the consultation time, the GPs and PNs thought
it helped improve patient engagement and quality of care.
In terms of its specific impact on the provision of care
for diabetes, it was found that most GPs and both PNs
used the tool mainly as an aid in managing patient life-
style changes rather than for other purposes such as
helping manage medications prescribing, referral and
follow-up. Therefore the full capacity of the tool was not
being used by most study participants. Generally, the
tool did not help GPs or PNs in managing the annual
cycle of care recommended by diabetes guidelines, prob-
ably as it did not directly summarise or link with this
cycle of care.
In this study, a number of barriers were found to the
use of the tool and suggestions were provided in inter-
views by GPs and PNs on improving the tool: both relat-
ing to the tool’s shortcomings and training and support
to users. Some of those findings are consistent with
other research, which identified that barriers to the up-
take of electronic decision support tools included a lack
of a business case, shifting of costs for data collection
and management to the clinician, uncertainty about the
optimal level of decision support, lack of technical and
semantic standards, and resistance to electronic decision
support tool use by the time conscious GP [12].
This study has some limitations. Participating GPs, PNs
and patients are willing participants who showed interest
in this study. This sampling strategy would affect to some
extent generalizing the study findings beyond those parti-
cipants. This qualitative study is only a short-term study. It
cannot tell us if those positive impacts of the tool on con-
sultation process and delivering care to diabetic patients
would maintain in a longer time and how effective the tool
would be in improving patent clinical outcomes. The
study provided qualitative information only and further
evaluation is needed in the form of quantitative measure-
ments of change in GP and PN behaviour and in patient
level measures of process and outcomes of care related to
use of the decision support tool. Ideally this would be in a
randomised controlled trial as though there is evidence
that an electronic decision support system can improve
process of care and some clinical markers of quality of dia-
betes care the published literature is limited [13].
An issue for all information technology tools is whether
the uptake and use will be maintained and how a particu-
lar tool will fare in the face of competition. This evaluation
does not answer these questions but they are relevant ones
in the Australian context where new electronic decision
support tools are being disseminated such as the Primary-
Care Sidebar which is supported by the Royal Australian
College of General Practitioners [14].
Conclusions
Overall this qualitative analysis of GP and PN interviews
found that the EDS tool had a positive impact on the qual-
ity of care of type 2 diabetes, and improved the ability of
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GPs and PNs to more effectively manage consultations in
patients with type 2 diabetes, and the EDS tool was both
feasible and practical for use in the clinical setting.
Findings from this study also provide the basis for future
modification of the EDS tool and furthering its ability to
fit into the daily practice of managing patients with type 2
diabetes. Further work on the tool could address imple-
mentation strategies of improving the uptake of the tool,
with more structured training, enhancing certain func-
tions such as links to the annual cycle of care and its
speed when integrated into patient management software.
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